Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials

INTRODUCTION: The recurrence rate of common bile duct stones (CBDS) after removal has been reported to exceed 10% and no established pharmacologic treatment exists for the prevention of recurrent CBDS. Many studies indicated ursodeoxycholic acid (UDCA) has the potential to prevent the recurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xun, Yan, Xiao-Ru, Zhang, Li-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250542/
https://www.ncbi.nlm.nih.gov/pubmed/30407311
http://dx.doi.org/10.1097/MD.0000000000013086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250542/
https://www.ncbi.nlm.nih.gov/pubmed/30407311
http://dx.doi.org/10.1097/MD.0000000000013086

Ejemplares similares